grant
Immune Tolerance Network
Organization BENAROYA RESEARCH INST AT VIRGINIA MASONLocation SEATTLE, UNITED STATESPosted 1 Feb 2014Deadline 31 Jan 2028
NIHUS FederalResearch GrantFY2025AddressAdoptedAnti-Rejection TherapyAreaAutoimmune DiseasesBrittle Diabetes MellitusCaliforniaClinicalClinical ResearchClinical StudyClinical TrialsDevelopmentDiagnosisDiseaseDisorderFreedomFundingFutureGoalsHealthHealth Care CostsHealth CostsIDDMImmune ToleranceImmunochemical ImmunologicImmunologicImmunologic ToleranceImmunologicalImmunologicallyImmunologicsImmunosuppressive TherapyInsulin-Dependent Diabetes MellitusJuvenile-Onset Diabetes MellitusKetosis-Prone Diabetes MellitusLaboratoriesLeadLeadershipLibertyMissionNIDDKNational Institute of Diabetes and Digestive and Kidney DiseasesPb elementPersonsQOL improvementResearchRoleSan FranciscoStructureSudden-Onset Diabetes MellitusT1 DMT1 diabetesT1DT1DMTherapeutic immunosuppressionType 1 Diabetes MellitusType 1 diabetesType I Diabetes MellitusUniversitiesWorkartificial immunosuppressionautoimmune conditionautoimmune disorderautoimmunity diseaseburden of diseaseburden of illnessclinical research siteclinical sitedesigndesigningdevelopmentaldisease burdenflexibilityflexibleheavy metal Pbheavy metal leadimmune system toleranceimmune unresponsivenessimmunological paralysisimmunosuppression therapyimprovements in QOLimprovements in quality of lifeinsightinsulin dependent diabetesinsulin dependent type 1interestjuvenile diabetesjuvenile diabetes mellitusketosis prone diabetesnovelpre-clinical studypreclinical studyprogramsquality of life improvementresponse to therapyresponse to treatmentsocial roletherapeutic responsetherapy responsetreatment responsetreatment responsivenesstrial planningtype I diabetestype one diabetes
Description preview
Jane Hoyt Buckner, MD (Contact)
Mark S. Anderson, MD
NIDDK Supplemental Funding Request
5UM1AI109565-12
Project Summary / Abstract
The mission of the Immune Tolerance Network (ITN) is to advance the clinical applicaƟon of
immune tolerance by conducƟng high-quality clinical trials of emerging therapeuƟcs based on
testable mechanisƟc hypotheses. The…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click